Reporting owner · CIK 0001073387

Bennett C Frank

Visual SEC Form 4 history across 1 companies, 35 transactions and 13 filings.

EVP, CSOEVP, Chief Scientific OfficerIONIS PHARMACEUTICALS INC
Open-market mix
Latest filingSep 03, 2026, 12:32 AM
Filings13Form 4 records
Buying$00 purchases
Selling$15.2M10 sales
Net value−$15.2MBuys minus sells
Companies14 securities
Most recentAug 31, 2026other

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-5Jan 242Jan 25Feb 252Jan 263Feb 263Mar 26Aug 26

Net value flow

Buys minus sells

Jan 24
$0
Jan 25
−$265.2K
Feb 25
$0
Jan 26
−$1.2M
Feb 26
−$7.1M
Mar 26
−$6.7M
Aug 26
$0

Transaction texture

Ownership and ticket size

Average P/S size$1.5M
Median P/S size$844K
Direct35
Indirect0
Aug 31, 2026other

Filing-only signals

Deterministic matches in this insider's history

Amended Filingfiling-context1Cluster Sellingpattern6Delayed Filingfiling-context1Derivative Transactionfiling-context13Direct Ownershipfiling-context34Large Holdings Increaseholdings9Large Holdings Reductionholdings6Large Salesize6Repeat Sellerpattern810b5-1 Detectedfiling-context7

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at IONIS PHARMACEUTICALS INC on Mar 03, 2026 valued at $64,771.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at IONIS PHARMACEUTICALS INC on Mar 03, 2026 valued at $64,771.

Review SEC filing

Associated companies

Visual map of known reporting history

IONSIONIS PHARMACEUTICALS INC35 transactions · latest Sep 03, 2026, 12:32 AM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
IONSBENNETT C FRANK
EVPCSO
exercise21.0k$0M
Derivative Transaction Direct Ownership Large Holdings Reduction
−3.4%01/2001/15
IONSBENNETT C FRANK
EVPCSO
grant25.8k$0A
Derivative Transaction Direct Ownership Large Holdings Increase
−3.4%01/2001/15
IONSBENNETT C FRANK
EVPCSO
sale8.97k-$67.4MS
Direct Ownership
−3.4%01/2001/16
IONSBENNETT C FRANK
EVPCSO
exercise21.0k$0M
Direct Ownership
−3.4%01/2001/15
IONSBENNETT C FRANK
EVPCSO
grant19.3k$0A
Derivative Transaction Direct Ownership Large Holdings Increase
−8.8%01/0601/02
IONSBENNETT C FRANK
EVPCSO
other320$902kJ
Direct Ownership
—03/04/202502/28/2025
IONSBENNETT C FRANK
EVPCSO
sale1.32k-$4.30MS
Cluster Selling Direct Ownership Repeat Seller
—02/04/202501/31/2025
IONSBENNETT C FRANK
EVPCSO
grant3.60k$0A
Direct Ownership
—02/04/202501/30/2025
IONSBENNETT C FRANK
EVPCSO
exercise18.0k$0M
Derivative Transaction Direct Ownership Large Holdings Reduction
—01/18/202501/15/2025
IONSBENNETT C FRANK
EVPCSO
grant33.0k$0A
Derivative Transaction Direct Ownership Large Holdings Increase
—01/18/202501/15/2025

Bennett C Frank Insider Activity FAQ

SEC Form 4 context

Who is Bennett C Frank?

Bennett C Frank is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001073387.

Which companies has Bennett C Frank reported transactions for?

IONIS PHARMACEUTICALS INC

When was Bennett C Frank's latest insider buy?

No open-market insider purchase is available for this period.

When was Bennett C Frank's latest insider sale?

sale at IONIS PHARMACEUTICALS INC on Mar 03, 2026 valued at $64,771.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.